Overview
- 113 inspections across 86 sites are on record.
- 194 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-03-05.
At a glance
Inspections
113
Sites
86
Observations
194
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Omrix Biopharmaceuticals Ltd. | 5 Mar 2020 | Biologics | View 483 → |
| OMRIX BIOPHARMACEUTICALS LTD | 24 Feb 2020 | Biologics | On file |
| Merck Teknika LLC | 24 Jan 2020 | Biologics | On file |
| MSD Ireland (Carlow) | 22 Nov 2019 | Biologics | View 483 → |
| Pfizer Ireland Pharmaceuticals Unlimited Company | 12 Nov 2019 | Biologics | View 483 → |
Sites inspected
Omrix Biopharmaceuticals Ltd.Nes-Ziona, Israel1 insp.
OMRIX BIOPHARMACEUTICALS LTDRamat Gan, Israel1 insp.
Merck Teknika LLCDurham, United States1 insp.
MSD Ireland (Carlow)Carlow, Ireland1 insp.
Pfizer Ireland Pharmaceuticals Unlimited CompanyDublin 22, Ireland1 insp.
Co-investigators
Investigators who share inspections with this person.
Omotunde O Osunsanmi12 shared
Susan M Jackson9 shared
Gene D Arcy7 shared
Cynthia Jim6 shared
Burnell M Henry4 shared
Helen B Ricalde4 shared
Steven E Bowen3 shared
Jacqueline M Diaz Albert3 shared
Michele L Forster3 shared
Paula A Trost3 shared
Full investigator report
Get the verbatim findings behind Mihaly S Ligmond's 194 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site